Johnson & Johnson (JNJ) Work In Process (2012 - 2018)
Johnson & Johnson (JNJ) posted Work In Process of $2.1 billion for Q4 2018, up 6.19% sequentially from $2.0 billion in Q3 2018, and down 8.98% YoY from $2.3 billion in Q4 2017.
Johnson & Johnson (JNJ) Work In Process (2012 - 2018) Analysis & Trends
Johnson & Johnson has reported Work In Process for 6 years, with the latest figure at $2.1 billion in Q4 2018.
- Quarterly Work In Process fell 8.98% year-over-year to $2.1 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $2.1 billion (down 8.98% YoY) and the FY2018 annual result came in at $2.1 billion, down 8.98% from the prior year.
- Work In Process rose to $2.1 billion in Q4 2018 per JNJ's latest filing, from $2.0 billion in the prior quarter.
- Over five years, Work In Process peaked at $2.5 billion in Q4 2014 and troughed at $2.0 billion in Q3 2018.
- A 4-year average of $2.2 billion and a median of $2.2 billion in 2016 frame the typical range for Work In Process.
- The sharpest annual moves came in 2017 and 2018: Work In Process advanced 6.04% in 2017, then dropped 8.98% in 2018.
- Over 4 years, Work In Process stood at $2.5 billion in 2014, then dropped by 8.94% to $2.2 billion in 2016, then gained by 3.39% to $2.3 billion in 2017, then retreated by 8.98% to $2.1 billion in 2018.
- According to Business Quant data, Work In Process over the past three periods registered $2.1 billion, $2.0 billion, and $2.3 billion for Q4 2018, Q3 2018, and Q3 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 30, 2018 | 2.11 Bn |
| Sep 30, 2018 | 1.99 Bn |
| Jul 1, 2018 | 2.28 Bn |
| Dec 31, 2017 | 2.32 Bn |
| Jan 1, 2017 | 2.19 Bn |
| Jan 3, 2016 | 2.24 Bn |
| Dec 28, 2014 | 2.46 Bn |
| Dec 29, 2013 | 2.61 Bn |
| Dec 30, 2012 | 2.26 Bn |
| Jan 1, 2012 | 1.64 Bn |